Belkina, N. V, Liu, Y., Hao, J.-J., Karasuyama, H., and Shaw, S. (2009). LOK is a major ERM kinase in resting lymphocytes and regulates cytoskeletal rearrangement through ERM phosphorylation. PNAS 106, 4707-4712.
Endo, J., Toyama-Sorimachi, N., Taya, C., Kuramochi-Miyagawa, S., Nagata, K., Kuida, K., Takashi, T., Yonekawa, H., Yoshizawa, Y., Miyasaka, N., et al. (2000). Deficiency of a STE20/PAK family kinase LOK leads to the acceleration of LFA-1 clustering and cell adhesion of activated lymphocytes. FEBS Lett. 468, 234-238.
Johnson, T.M., Antrobus, R., and Johnson, L.N. (2008). Plk1 activation by Ste20-like kinase (Slk) phosphorylation and polo-box phosphopeptide binding assayed with the substrate translationally controlled tumor protein (TCTP). Biochemistry 47, 3688-3696.
Kuramochi, S., Moriguchi, T., Kuida, K., Endo, J., Semba, K., Nishida, E., and Karasuyama, H. (1997). LOK Is a Novel Mouse STE20-like Protein Kinase That Is Expressed Predominantly in Lymphocytes. J. Biol. Chem. 272, 22679-22684.
Qian, Y.-W., Erikson, E., and Maller, J.L. (1998). Purification and Cloning of a Protein Kinase That Phosphorylates and Activates the Polo-Like Kinase Plx1. Science (80-. ). 282, 1701-1704.
Viswanatha, R., Ohouo, P.Y., Smolka, M.B., and Bretscher, A. (2012). Local phosphocycling mediated by LOK/SLK restricts ezrin function to the apical aspect of epithelial cells. J. Cell Biol. 199, 969-984.
Walter, S. a, Cutler, R.E., Martinez, R., Gishizky, M., and Hill, R.J. (2003). Stk10, a new member of the polo-like kinase kinase family highly expressed in hematopoietic tissue. J. Biol. Chem. 278, 18221-18228.
Yamamoto, N., Honma, M., and Suzuki, H. (2011). Off-target serine/threonine kinase 10 inhibition by erlotinib enhances lymphocytic activity leading to severe skin disorders. Mol. Pharm. 80, 466-475.